as on October 25, 2025 at 1:29 am IST
Day's Low
Day's High
1.30%
Downside
1.30%
Upside
52 Week's Low
52 Week's High
43.12%
Downside
371.95%
Upside
Check Rocket Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$415.4M
EPS (TTM)
-2.1296
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-253.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-69.65%
Compare market cap, revenue, PE, and other key metrics of Rocket Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $415.4M | -86.3% | NA | 0.00% | |
| BUY | $60.9B | 251.51% | -505.15 | -12.96% | |
| NA | $35.7B | NA | NA | -3.89% | |
| BUY | $109.3B | 99.16% | 30.04 | 31.86% | |
| BUY | $62.0B | -0.32% | 14.51 | 31.37% |
The Rocket Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Rocket Pharmaceuticals Inc investment value today
Current value as on today
₹27,200
Returns
Returns from Rocket Pharmaceuticals Inc Stock
Dollar Returns*
₹4,606 (+4.61%)
Based on 21 analysts
90.48%
Buy
9.52%
Hold
0.00%
Sell
Based on 21 analysts, 90.48% of analysts recommend a 'BUY' rating for Rocket Pharmaceuticals Inc. Average target price of $7.73
Get share price movements and forecasts by analysts on Rocket Pharmaceuticals Inc.
What analysts predicted
50.19%UPSIDE
Target Price
$7.73
Current Price
$3.85
Analyzed by
21 Analysts
Target
$7.73
Rocket Pharmaceuticals Inc target price $7.73, a slight upside of 50.19% compared to current price of $3.85. According to 21 analysts rating.
Search interest for Rocket Pharmaceuticals Inc Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:16% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 20 August
Wed, 05:05 PM
-FDA lifts clinical hold on Rocket Pharmaceuticals' RP-A501 gene therapy trial for Danon disease, allowing it to resume with adjusted dosing.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, RCKT stock has moved up by 18.1%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.7% return, outperforming this stock by 140.1%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 130.5% return, outperforming this stock by 209.5%
| Organisation | Rocket Pharmaceuticals Inc |
| Headquarters | 9 Cedarbrook Drive, Cranbury, NJ, United States, 08512 |
| Industry | Health Technology |
| CEO | Dr. Gaurav D. Shah M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Gayatri R. Rao J.D., M.D. | Senior VP of Clinical Safety & Chief Regulatory Officer |
Ms. Sarbani Chaudhuri M.B.A. | Chief Commercial & Medical Affairs Officer |
Dr. Syed Ali-Aamir Rizvi M.D. | Chief Medical Officer |
Dr. Gaurav D. Shah M.D. | CEO & Director |
Mr. Martin Louis Wilson J.D. | Gen. Counsel, Secretary, Interim Prin. Financial Officer, Chief Comp. Officer & Chief Corp. Officer |
Mr. Christopher Stevens | Chief Operating Officer |
Ms. Meg Dodge J.D., L.L.M. | Senior Vice President & Head of External Affairs |
Kevin Giordano | Director of Corporate Communications |
Dr. Jonathan Schwartz M.D. | Chief Science & Gene Therapy Officer |
Dr. Kinnari Patel M.B.A., Pharm.D. | Executive Officer |
Rocket Pharmaceuticals Inc share price today is $3.85 as on at the close of the market. Rocket Pharmaceuticals Inc share today touched a day high of $3.9 and a low of $3.8.
Rocket Pharmaceuticals Inc share touched a 52 week high of $18.17 on and a 52 week low of $2.19 on . Rocket Pharmaceuticals Inc stock price today i.e. is closed at $3.85,which is 78.81% down from its 52 week high and 75.80% up from its 52 week low.
Rocket Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Rocket Pharmaceuticals Inc (RCKT) shares with as little as ₹87.796 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.96 in Rocket Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Rocket Pharmaceuticals Inc share’s latest price of $3.85 as on October 25, 2025 at 1:29 am IST, you will get 2.5974 shares of Rocket Pharmaceuticals Inc. Learn more about
fractional shares .
Rocket Pharmaceuticals Inc stock has given -86.3% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?